Delafloxacin Meglumine Patent Expiration
Delafloxacin Meglumine is used for treating acute bacterial skin infections in adults. It was first introduced by Melinta Subsidiary Corp
Delafloxacin Meglumine Patents
Given below is the list of patents protecting Delafloxacin Meglumine, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Baxdela | US7635773 | Sulfoalkyl ether cyclodextrin compositions | Mar 13, 2029 | Melinta |
| Baxdela | US7728143 | Salt and crystalline forms thereof of a drug | Jun 19, 2031 | Melinta |
| Baxdela | US8252813 | Salt and crystalline forms thereof of a drug | Oct 02, 2026 | Melinta |
| Baxdela | US8273892 | Salt and crystalline forms thereof of a drug | Aug 06, 2026 | Melinta |
| Baxdela | US8410077 | Sulfoalkyl ether cyclodextrin compositions | Mar 13, 2029 | Melinta |
| Baxdela | US8497378 | Process for making quinolone compounds | Dec 28, 2029 | Melinta |
| Baxdela | US8648093 | Salt and crystalline forms thereof of a drug | Oct 07, 2025 | Melinta |
| Baxdela | US8871938 | Process for making quinolone compounds | Sep 23, 2029 | Melinta |
| Baxdela | US8969569 | Salt and crystalline forms thereof of a drug | Oct 07, 2025 | Melinta |
| Baxdela | US9200088 | Sulfoalkyl ether cyclodextrin compositions | Mar 13, 2029 | Melinta |
| Baxdela | US9493582 | Alkylated cyclodextrin compositions and processes for preparing and using the same | Feb 27, 2033 | Melinta |
| Baxdela | US9539250 | Salt and crystalline forms thereof of a drug | Oct 07, 2025 | Melinta |
| Baxdela | US9750822 | Sulfoalkyl ether cyclodextrin compositions | Mar 13, 2029 | Melinta |
| Baxdela | USRE46617 | Process for making quinolone compounds | Dec 28, 2029 | Melinta |
Coming Soon
Patent Strength Analyzer
YesNo
Thank you for your response 🥳